Blood Pressure Control May Prevent Over 100,000 Deaths
According to findings from a new study presented at ASN Kidney Week November 15-20 November 2016 at McCormick Place in Chicago, IL, intensive blood pressure lowering may prevent more than 100,000 deaths in the U.S. each year.
The Systolic Blood Pressure Intervention Trial (SPRINT) trial, the largest study of its kind, was conducted with more than 9300 participants aged 50 and older with high blood pressure. Patients were assigned to a systolic blood pressure target of 120 mm Hg or the 140mm Hg and were prescribed medication accordingly. Findings showed that intensive systolic blood pressure lowering to 120 mm Hg prolonged life compared with the standard SBP lowering to 140mm Hg.
See Also: SPRINT Study: Lowering Blood Pressure Lowers CVD Events
Tisha Joerla Tan, MD (Loyola University Medical Center) and her colleagues applied the study's findings to similar individuals in the general US population. Approximately 18.1 million US adults met SPRINT criteria. Intensive blood pressure lowering was projected to prevent nearly 105,000 deaths per year.
"Our analyses also showed that more than 4 million adults with stage 3-4 chronic kidney disease meet SPRINT criteria, and intensive systolic blood pressure lowering was projected to prevent 32,800 deaths per year in this group," said Dr. Tan.
Source: American Society of Nephrology
Image Credit: Pixabay
Published on : Sun, 20 Nov 2016
Unbelievably small and light mechanical chest compression device In case of a sudden cardiac arrest, immediate chest compressions are required. Performing manual chest compressions well for an extended period of time is almost impossible. Thanks to...
Automatic external defibrillator / with ECG monitor / public access FRED easyport SCHILLER
FRED easyport is an incredibly small and light pocket defibrillator, equipped with the effective and myocardium-saving defibrillation impulse called Multipulse Biowave. FRED easyport is the ideal companion for physicians, public service staff, even...
By lifting up the device cover, the FRED PA-1 starts up immediately and guides the rescuer step-by-step during the entire resuscitation process. The FRED PA-1 is available either as semi-automatic or fully automatic device.In its automatic version,...
The Task Force® Monitor is the all‐in‐one workstation for continuous noninvasive hemodynamic and autonomic assessment. It is the state‐of‐the‐art diagnostic tool to study syncope and autoregulation of blood pressure and has further established as an...
Proven 6-channel ECG performance The most important cardiopulmonary function tests are combined in one single device: resting ECG and exercise ECG. Ready for networking with XML output.